We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$308M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$188M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$172M
4
PSA icon
Public Storage
PSA
+$47.9M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$46.9M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$53.7M
2
MCD icon
McDonald's
MCD
+$46.3M
3
SO icon
Southern Company
SO
+$33.8M
4
HEWJ icon
iShares Currency Hedged MSCI Japan ETF
HEWJ
+$26.3M
5
ETP
Energy Transfer Partners L.p.
ETP
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPA icon
501
Invesco Aerospace & Defense ETF
PPA
$8.48B
$16.6M 0.04%
360,704
-704
-0.2% -$31.8K
STT icon
502
State Street
STT
$50.5B
$16.5M 0.04%
183,470
+6,911
+4% +$575K
FDUS icon
503
Fidus Investment
FDUS
$766M
$16.4M 0.04%
973,555
+55,179
+6% +$951K
AAOI icon
504
Applied Optoelectronics
AAOI
$8.84B
$16.3M 0.04%
264,575
+112,370
+74% +$6.56M
LRCX icon
505
Lam Research
LRCX
$369B
$16.3M 0.04%
1,149,860
-16,980
-1% -$249K
EZU icon
506
iShare MSCI Eurozone ETF
EZU
$9.73B
$16.3M 0.04%
403,204
+276,050
+217% +$11M
WAT icon
507
Waters Corp
WAT
$36.8B
$16.2M 0.04%
88,231
+7,443
+9% +$1.29M
AYR
508
DELISTED
Aircastle Ltd
AYR
$16.2M 0.04%
745,507
+19,250
+3% +$433K
SWKS icon
509
Skyworks Solutions
SWKS
$9.22B
$16.2M 0.04%
168,750
+971
+0.6% +$99.6K
ADM icon
510
Archer Daniels Midland
ADM
$37.6B
$16.2M 0.04%
390,933
-20,408
-5% -$876K
TEVA icon
511
Teva Pharmaceuticals
TEVA
$40.2B
$16.2M 0.04%
486,848
+63,221
+15% +$1.96M
SHPG
512
DELISTED
Shire pic
SHPG
$16.1M 0.03%
97,683
-23,327
-19% -$4.08M
RWJ icon
513
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.1B
$16.1M 0.03%
733,158
+53,388
+8% +$1.17M
IQV icon
514
IQVIA
IQV
$38.4B
$16.1M 0.03%
180,235
-19,640
-10% -$1.66M
ZBH icon
515
Zimmer Biomet
ZBH
$18.8B
$16M 0.03%
128,716
+2,666
+2% +$316K
PBCT
516
DELISTED
People's United Financial Inc
PBCT
$16M 0.03%
907,250
-5,603
-0.6% -$97.4K
GSIE icon
517
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.03B
$16M 0.03%
578,208
+36,840
+7% +$1M
EXPE icon
518
Expedia Group
EXPE
$35.8B
$15.9M 0.03%
107,066
+21,245
+25% +$2.98M
SRCL
519
DELISTED
Stericycle Inc
SRCL
$15.9M 0.03%
208,818
-37
-0% -$3.04K
KR icon
520
Kroger
KR
$35.7B
$15.9M 0.03%
682,797
+315,217
+86% +$8.94M
FXG icon
521
First Trust Consumer Staples AlphaDEX Fund
FXG
$226M
$15.9M 0.03%
346,020
+3,016
+0.9% +$140K
LYG icon
522
Lloyds Banking Group
LYG
$90.8B
$15.8M 0.03%
4,480,746
-5,233
-0.1% -$18.6K
ALK icon
523
Alaska Air
ALK
$5.6B
$15.8M 0.03%
175,476
+16,083
+10% +$1.41M
TTC icon
524
Toro Company
TTC
$9.06B
$15.7M 0.03%
226,607
+37,569
+20% +$2.51M
TKR icon
525
Timken Company
TKR
$9.85B
$15.7M 0.03%
338,385
+37,409
+12% +$1.72M
19 20
21
22 23

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.